van den Boom Esther 4
4 · Tyra Biosciences, Inc. · Filed Sep 17, 2021
Insider Transaction Report
Form 4
van den Boom Esther
Chief Financial Officer
Transactions
- Conversion
Series A Preferred Stock
2021-09-17−8,183→ 0 total→ Common Stock (21,254 underlying) - Conversion
Common Stock
2021-09-17+21,254→ 21,254 total(indirect: See footnote)
Holdings
- 118,645
Common Stock
Footnotes (3)
- [F1]On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F2]Represents shares held by van den Boom Ventures LLC, of which the spouse of the Reporting Person is the managing member.
- [F3]Includes 71,674 shares subject to repurchase by us, which are subject to vesting.